clivatuzumab tetraxetan

Immunomedics Reports Final Efficacy Results of Phase Ib Trial With Yttrium-90-Labeled Clivatuzumab Tetraxetan in Patients With Metastatic Pancreatic Cancer
Yahoo/Globe Newswire
Sun, 06/1/14 - 11:31 am
Immunomedics
pancreatic cancer
clivatuzumab tetraxetan
gemcitabine